©The Author(s) 2025.
World J Gastrointest Surg. Nov 27, 2025; 17(11): 110306
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.110306
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.110306
Table 2 Univariate and multivariate regression analyses to predict malignancy or high-grade dysplasia
| Parameters | Univariate analysis OR (95%CI) | P value | Multivariate analysis OR (95%CI) | P value |
| Age | 1.095 (1.042-1.150) | < 0.001 | 1.067 (1.014-1.122) | 0.012 |
| Male gender | 2.574 (0.957-6.925) | 0.061 | ||
| Diabetes mellitus | 4.889 (1.710-13.977) | 0.003 | ||
| Red cell distribution width | 2.240 (1.485-3.380) | < 0.001 | 1.784 (1.172-2.715) | 0.007 |
| Neutrophil-lymphocyte ratio | 1.145 (0.927-1.414) | 0.208 | ||
| Platelet-lymphocyte ratio | 1.005 (0.999-1.012) | 0.092 | ||
| Albumin | 0.914 (0.844-0.989) | 0.026 | ||
| CA 19-9 | 1.003 (0.999-1.007) | 0.152 |
- Citation: Martli HF, Acehan F, Şimşek A, Şahingöz E, Sürel AA, Er S, Tez M. Preoperative malignancy risk assessment in pancreatic cystic neoplasms using clinical and laboratory parameters. World J Gastrointest Surg 2025; 17(11): 110306
- URL: https://www.wjgnet.com/1948-9366/full/v17/i11/110306.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i11.110306